MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0016569
Kelly Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.56 Cr
▲ 19% YoY
Net profit · FY 2024
₹1.28 Lakh
Net margin 0.8%
EBITDA · FY 2024
₹2.23 Lakh
EBITDA margin 1.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Kelly Pharmaceuticals Private Limited
Data last updated:
Kelly Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC333086. Its GSTIN is 10AAHCK0795L1ZF (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Niti Kumar Choubey (Managing Director) and Kumari Shikha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Vimlesh Dubey S/O – Ram Adhar A – 36 Deepak Vihar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.56 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.28 Lakh (net margin 0.8%) and EBITDA of ₹2.23 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 41% over five years.
Kelly Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0016569). For more details, the company can be reached via its website kellypharmaceuticals.com.
Company details
CIN U51909DL2018PTC333086
Registration Number 333086
Incorporation Date 25 April 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0016569
Recognitions & Rankings of Kelly Pharmaceuticals
Contact details
Kelly Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is kellypharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O – Vimlesh Dubey S/O – Ram Adhar A – 36 Deepak Vihar, New Delhi, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Kelly Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Kelly Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kelly Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kelly Pharmaceuticals Private Limited, buy the company report.
Financials of Kelly Pharmaceuticals Private Limited
FY 2025 filings availableKelly Pharmaceuticals Private Limited reported revenue of ₹1.56 Cr (up 19% YoY) for FY 2024.
Revenue · FY 2024
₹1.56 Cr ▲ 19%
Net profit · FY 2024
₹1.28 Lakh margin 0.8%
EBITDA · FY 2024
₹2.23 Lakh margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 51%
5 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▼ 29%
3 years · compounded
▲ 26%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 19% growth in the latest year. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kelly Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kelly Pharmaceuticals Private Limited
Kelly Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Niti Kumar Choubey Also directs: Edhanu India Private Limited | Managing Director | 25 Apr 2018 | 8 Years 6 Months | Current |
| Kumari Shikha Also directs: Edhanu India Private Limited | Director | 23 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Kelly Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Xander Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2025) | Perintalmanna, Kerala, India | ||||
| Ginsburg Drugs and Formulations Private Limited | ₹1.56 Cr (FY 2024) | -1.0% | Gorakhpur, Uttar Pradesh, India | |||
| Vivion Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2025) | 15.0% | Jaipur, Rajasthan, India | |||
| Euromedicare International Private Limited | ₹1.56 Cr (FY 2025) | -4.0% | Hyderabad, Telangana, India | |||
| Kelly Pharmaceuticals Private Limitedthis company | ₹1.56 Cr (FY 2024) | ₹1.28 Lakh | 0.8% | 19.0% | New Delhi, Delhi, India | |
| Pollen Pharma Private Limited | ₹1.55 Cr (FY 2025) | 1.0% | Jabalpur, Madhya Pradesh, India |
To see the full peer comparison of Kelly Pharmaceuticals Private Limited, buy the company report.
Auditor
Kelly Pharmaceuticals Private Limited is audited by DUSHYANT KUMAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DUSHYANT KUMAR & CO | FY 2021 | 020157C |
Shareholding
The shareholding of Kelly Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kelly Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kelly Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kelly Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kelly Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCK0795L1ZF | Bihar | Active | 15 Jun 2018 |
To see the full GST registrations and return filing status of Kelly Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kelly Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Abdul Kadir ceased to be Director on 18 Dec 2025.
Ceased
Abdul Kadir ceased to be Director.
Appointed
Kumari Shikha was appointed as Director.
AGM
Kelly Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kelly Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Nishi Kumari ceased to be Director.
Appointed
Niti Kumar Choubey was appointed as Managing Director.
Incorporation
25 Apr 2018
Kelly Pharmaceuticals Private Limited was registered on 25 Apr 2018 with Roc Delhi & aged 8 years 6 months as per MCA records.
Frequently asked questions
Kelly Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 April 2018 (8+ years old) and is registered under CIN U51909DL2018PTC333086.
Kelly Pharmaceuticals has 2 current directors:
- Niti Kumar Choubey - Managing Director
- Kumari Shikha - Director
The latest financial statements of Kelly Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Kelly Pharmaceuticals is 10AAHCK0795L1ZF, registered in Bihar.
The CIN (Corporate Identification Number) of Kelly Pharmaceuticals is U51909DL2018PTC333086. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kelly Pharmaceuticals was incorporated on 25 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Kelly Pharmaceuticals by revenue are Xander Pharmaceuticals Private Limited, Ginsburg Drugs and Formulations Private Limited, Vivion Pharmaceuticals Private Limited, Euromedicare International Private Limited, Pollen Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Abdul Kadir ceased to be Director on 18 Dec 2025. Kumari Shikha was appointed as Director on 23 Nov 2025. Nishi Kumari ceased to be Director on 03 Feb 2022. Kelly Pharmaceuticals has 4 board changes on record in total.
Yes, Kelly Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0016569).
Kelly Pharmaceuticals can be reached through the website kellypharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Kelly Pharmaceuticals is at CO – Vimlesh Dubey SO – Ram Adhar A – 36 Deepak Vihar, New Delhi, Delhi, India – 110059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages